David G. Standaert, M.D., Ph.D. - Related publications

Affiliations: 
Neurology University of Alabama, Birmingham, Birmingham, AL, United States 
Area:
Parkinson's disease
NOTE: We are testing a new system for identifying relevant work based on semantic analysis that identifies similarities between recently published papers and the current author's publications. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches.
50 most relevant papers in past 60 days:
Year Citation  Score
2020 Belloli S, Morari M, Murtaj V, Valtorta S, Moresco RM, Gilardi MC. Translation Imaging in Parkinson's Disease: Focus on Neuroinflammation. Frontiers in Aging Neuroscience. 12: 152. PMID 32581765 DOI: 10.3389/fnagi.2020.00152   
2020 Huang Y, Sun L, Zhu S, Xu L, Liu S, Yuan C, Guo Y, Wang X. Neuroprotection Against Parkinson's Disease Through the Activation of Akt/GSK3β Signaling Pathway by Tovophyllin A. Frontiers in Neuroscience. 14: 723. PMID 32742256 DOI: 10.3389/fnins.2020.00723   
2020 Inose Y, Izumi Y, Takada-Takatori Y, Akaike A, Koyama Y, Kaneko S, Kume T. Protective effects of Nrf2-ARE activator on dopaminergic neuronal loss in Parkinson disease model mice: Possible involvement of heme oxygenase-1. Neuroscience Letters. 736: 135268. PMID 32712353 DOI: 10.1016/j.neulet.2020.135268   
2020 Chang YM, Manoj Kumar M, Lu CY, Te Tsai C, Tsai CC, Liao PH, Lin SL, Chang CC, Mahalakshmi B, Kuo WW, Huang CY. Parkinson's disease a futile entangle of Mankind's credence on an herbal remedy: A review. Life Sciences. 118019. PMID 32629002 DOI: 10.1016/j.lfs.2020.118019   
2020 Getachew B, Csoka AB, Bhatti A, Copeland RL, Tizabi Y. Butyrate Protects Against Salsolinol-Induced Toxicity in SH-SY5Y Cells: Implication for Parkinson's Disease. Neurotoxicity Research. PMID 32572814 DOI: 10.1007/s12640-020-00238-5   
2020 Lei K, Shen Y, He Y, Zhang L, Zhang J, Tong W, Xu Y, Jin L. Baicalin Represses C/EBP via Its Antioxidative Effect in Parkinson's Disease. Oxidative Medicine and Cellular Longevity. 2020: 8951907. PMID 32566108 DOI: 10.1155/2020/8951907   
2020 Pajares M, I Rojo A, Manda G, Boscá L, Cuadrado A. Inflammation in Parkinson's Disease: Mechanisms and Therapeutic Implications. Cells. 9. PMID 32674367 DOI: 10.3390/cells9071687   
2020 Buckner N, Kemp KC, Scott HL, Shi G, Rivers C, Gialeli A, Wong LF, Cordero-LLana O, Allen N, Wilkins A, Uney JB. Abnormal scaffold attachment factor 1 expression and localisation in spinocerebellar ataxias and huntington's chorea. Brain Pathology (Zurich, Switzerland). PMID 32580238 DOI: 10.1111/bpa.12872   
2020 Hoban DB, Shrigley S, Mattsson B, Breger LS, Jarl U, Cardoso T, Nelander Wahlestedt J, Luk KC, Björklund A, Parmar M. Impact of α-synuclein pathology on transplanted hESC-derived dopaminergic neurons in a humanized α-synuclein rat model of PD. Proceedings of the National Academy of Sciences of the United States of America. PMID 32541058 DOI: 10.1073/pnas.2001305117   
2020 Wang M, Ling KH, Tan JJ, Lu CB. Development and Differentiation of Midbrain Dopaminergic Neuron: From Bench to Bedside. Cells. 9. PMID 32570916 DOI: 10.3390/cells9061489   
2020 Angelopoulou E, Paudel YN, Shaikh MF, Piperi C. Fractalkine (CX3CL1) signaling and neuroinflammation in Parkinson's disease: Potential clinical and therapeutic implications. Pharmacological Research. 158: 104930. PMID 32445958 DOI: 10.1016/j.phrs.2020.104930   
2020 Wang Y, Wang Q, Yu R, Zhang Q, Zhang Z, Li H, Ren C, Yang R, Niu H. Minocycline inhibition of microglial rescues nigrostriatal dopaminergic neurodegeneration caused by mutant alpha-synuclein overexpression. Aging. 12. PMID 32706757 DOI: 10.18632/aging.103440   
2020 Tsai RT, Tsai CW, Liu SP, Gao JX, Kuo YH, Chao PM, Hung HS, Shyu WC, Lin SZ, Fu RH. Maackiain Ameliorates 6-Hydroxydopamine and Pathologies by Modulating the PINK1/Parkin Pathway in Models of Parkinson's Disease in and the SH-SY5Y Cell Line. International Journal of Molecular Sciences. 21. PMID 32585871 DOI: 10.3390/ijms21124455   
2020 Liao JF, Cheng YF, You ST, Kuo WC, Huang CW, Chiou JJ, Hsu CC, Hsieh-Li HM, Wang S, Tsai YC. Lactobacillus plantarum PS128 alleviates neurodegenerative progression in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse models of Parkinson's disease. Brain, Behavior, and Immunity. PMID 32739365 DOI: 10.1016/j.bbi.2020.07.036   
2020 Wang Y, Bouabid S, Darvas M, Zhou FM. The antiparkinson drug ropinirole inhibits movement in a Parkinson's disease mouse model with residual dopamine neurons. Experimental Neurology. 113427. PMID 32735872 DOI: 10.1016/j.expneurol.2020.113427   
2020 Chen H, Cao J, Zha L, Wang P, Liu Z, Guo B, Zhang G, Sun Y, Zhang Z, Wang Y. Neuroprotective and neurogenic effects of novel tetramethylpyrazine derivative T-006 in Parkinson's disease models through activating the MEF2-PGC1α and BDNF/CREB pathways. Aging. 12. PMID 32710729 DOI: 10.18632/aging.103551   
2020 Li W, Goshima Y, Ohshima T. Loss of Collapsin Response Mediator Protein 4 Attenuates 6-Hydroxydopamine-Induced Impairments in a Mouse Model of Parkinson's Disease. Neurochemical Research. PMID 32648145 DOI: 10.1007/s11064-020-03086-z   
2020 Yang L, Mao K, Yu H, Chen J. Neuroinflammatory Responses and Parkinson' Disease: Pathogenic Mechanisms and Therapeutic Targets. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 32529463 DOI: 10.1007/s11481-020-09926-7   
2020 Shin HW, Chung SJ, Lee S, Cha J, Sohn YH, Yun M, Lee PH. Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease. Clinical Nuclear Medicine. PMID 32520498 DOI: 10.1097/RLU.0000000000003107   
2020 Naz F, Rahul, Fatima M, Naseem S, Khan W, Mondal AC, Siddique YH. Ropinirole silver nanocomposite attenuates neurodegeneration in the transgenic Drosophila melanogaster model of Parkinson's disease. Neuropharmacology. 108216. PMID 32707222 DOI: 10.1016/j.neuropharm.2020.108216   
2020 Baldini F, Hertel J, Sandt E, Thinnes CC, Neuberger-Castillo L, Pavelka L, Betsou F, Krüger R, Thiele I, . Parkinson's disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions. Bmc Biology. 18: 62. PMID 32517799 DOI: 10.1186/s12915-020-00775-7   
2020 Travagli RA, Browning KN, Camilleri M. Parkinson disease and the gut: new insights into pathogenesis and clinical relevance. Nature Reviews. Gastroenterology & Hepatology. PMID 32737460 DOI: 10.1038/s41575-020-0339-z   
2020 El-Ghaiesh SH, Bahr HI, Ibrahiem AT, Ghorab D, Alomar SY, Farag NE, Zaitone SA. Metformin Protects From Rotenone-Induced Nigrostriatal Neuronal Death in Adult Mice by Activating AMPK-FOXO3 Signaling and Mitigation of Angiogenesis. Frontiers in Molecular Neuroscience. 13: 84. PMID 32625061 DOI: 10.3389/fnmol.2020.00084   
2020 Zhao H, Huang S, Palanisamy S, Wang C, Rainer G, Zhang X. Alpha-synuclein Dopaminylation Presented in Plasma of Both Healthy Subjects and Parkinson's Disease Patients. Proteomics. Clinical Applications. e1900117. PMID 32538547 DOI: 10.1002/prca.201900117   
2020 Hernández-Vara J, Sáez-Francàs N, Lorenzo-Bosquet C, Corominas-Roso M, Cuberas-Borròs G, Lucas-Del Pozo S, Carter S, Armengol-Bellapart M, Castell-Conesa J. BDNF levels and nigrostriatal degeneration in "drug naïve" Parkinson's disease patients. An "in vivo" study using I-123-FP-CIT SPECT. Parkinsonism & Related Disorders. 78: 31-35. PMID 32682292 DOI: 10.1016/j.parkreldis.2020.06.037   
2020 Awogbindin IO, Ishola IO, St-Pierre MK, Carrier M, Savage JC, Di Paolo T, Tremblay MÈ. Remodeling microglia to a protective phenotype in Parkinson's disease? Neuroscience Letters. 135164. PMID 32561452 DOI: 10.1016/j.neulet.2020.135164   
2020 Huang J, Hong W, Yang Z, Ding J, Ren Y. Efficacy of pramipexole combined with levodopa for Parkinson's disease treatment and their effects on QOL and serum TNF- levels. The Journal of International Medical Research. 48: 300060520922449. PMID 32735501 DOI: 10.1177/0300060520922449   
2020 Raina A, Leite K, Guerin S, Mahajani SU, Chakrabarti KS, Voll D, Becker S, Griesinger C, Bähr M, Kügler S. Dopamine promotes the neurodegenerative potential of β-synuclein. Journal of Neurochemistry. PMID 32730640 DOI: 10.1111/jnc.15134   
2020 Østergaard FG, Himmelberg MM, Laursen B, Siebner HR, Wade AR, Christensen KV. Classification of α-synuclein-induced changes in the AAV α-synuclein rat model of Parkinson's disease using electrophysiological measurements of visual processing. Scientific Reports. 10: 11869. PMID 32681050 DOI: 10.1038/s41598-020-68808-3   
2020 Pavlenko TA, Chesnokova NB, Nodel MR, Kim AR, Ugrumov MV. Molecular Mechanisms and Clinical Manifestations of Catecholamine Dysfunction in the Eye in Parkinson's Disease As a Basis for Developing Early Diagnosis. Acta Naturae. 12: 52-62. PMID 32742727 DOI: 10.32607/actanaturae.10906   
2020 Hossein-Tehrani MR, Ghaedian T, Hooshmandi E, Kalhor L, Foroughi AA, Ostovan VR. Brain TRODAT-SPECT Versus MRI Morphometry in Distinguishing Early Mild Parkinson's Disease from Other Extrapyramidal Syndromes. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 32557946 DOI: 10.1111/jon.12740   
2020 Joers V, Masilamoni G, Kempf D, Weiss AR, Rotterman TM, Murray B, Yalcin-Cakmakli G, Voll RJ, Goodman MM, Howell L, Bachevalier J, Green S, Naqib A, Shaikh M, Engen P, et al. Microglia, inflammation and gut microbiota responses in a progressive monkey model of Parkinson's disease: A case series. Neurobiology of Disease. 105027. PMID 32712266 DOI: 10.1016/j.nbd.2020.105027   
2020 Kao CY, Xu M, Wang L, Lin SC, Lee HJ, Duraine L, Bellen HJ, Goldstein DS, Tsai SY, Tsai MJ. Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction. Plos Genetics. 16: e1008868. PMID 32579581 DOI: 10.1371/journal.pgen.1008868   
2020 Yu J, Min D, Bai Y, Qu L, Zou T, Wang S. Electroacupuncture alleviates Parkinson disease and regulates the expression of brain-gut peptides. Experimental Animals. PMID 32669479 DOI: 10.1538/expanim.19-0153   
2020 Yu J, Min D, Bai Y, Qu L, Zou T, Wang S. Electroacupuncture alleviates Parkinson disease and regulates the expression of brain-gut peptides. Experimental Animals. PMID 32669479 DOI: 10.1538/expanim.19-0153   
2020 Thomas Broome S, Louangaphay K, Keay KA, Leggio GM, Musumeci G, Castorina A. Dopamine: an immune transmitter. Neural Regeneration Research. 15: 2173-2185. PMID 32594028 DOI: 10.4103/1673-5374.284976   
2020 Li W, Gao H, Li W. Effects of Combined Bushen Zhichan Recipe and Levodopa in a Rodent Model of Parkinson Disease: Potential Mechanisms. Medical Science Monitor : International Medical Journal of Experimental and Clinical Research. 26: e922345. PMID 32555131 DOI: 10.12659/MSM.922345   
2020 Farombi EO, Awogbindin IO, Olorunkalu PD, Ogbuewu E, Oyetunde BF, Agedah AE, Adeniyi PA. Kolaviron protects against nigrostriatal degeneration and gut oxidative damage in a stereotaxic rotenone model of Parkinson's disease. Psychopharmacology. PMID 32651640 DOI: 10.1007/s00213-020-05605-w   
2020 Dong XL, Wang X, Liu F, Liu X, Du ZR, Li RW, Xue CH, Wong KH, Wong WT, Zhao Q, Tang QJ. Polymannuronic acid prevents dopaminergic neuronal loss via brain-gut-microbiota axis in Parkinson's disease model. International Journal of Biological Macromolecules. PMID 32710966 DOI: 10.1016/j.ijbiomac.2020.07.180   
2020 Kam TI, Hinkle JT, Dawson TM, Dawson VL. Microglia and astrocyte dysfunction in parkinson's disease. Neurobiology of Disease. 105028. PMID 32736085 DOI: 10.1016/j.nbd.2020.105028   
2020 Barker RA, Bjorklund A, Gash DM, Whone A, Van Laar A, Kordower JH, Bankiewicz K, Kieburtz K, Saarma M, Booms S, Huttunen HJ, Kells A, Fiandaca MS, Stoessl AJ, Eidelberg D, et al. GDNF and Parkinson's Disease: Where Next? A Summary from a Recent Workshop. Journal of Parkinson's Disease. PMID 32508331 DOI: 10.3233/JPD-202004   
2020 Lei J, Ye G, Pertovaara A, You HJ. Effects of heating-needle stimulation in restoration of weakened descending inhibition of nociception in a rat model of Parkinson's disease. Neuroscience. PMID 32504795 DOI: 10.1016/j.neuroscience.2020.05.043   
2020 Wang J, Tan Y, Peng Q, Zeng W, Yang X, Chen C, Wu Y, Xu Y, Cao X. Structural brain changes in Ser129-phosphorylated alpha-synuclein rats based on voxel-based morphometry. Behavioural Brain Research. 112786. PMID 32592738 DOI: 10.1016/j.bbr.2020.112786   
2020 Chen Y, Zhu G, Liu D, Zhang X, Liu Y, Yuan T, Du T, Zhang J. Subthalamic nucleus deep brain stimulation suppresses neuroinflammation by Fractalkine pathway in Parkinson's disease rat model. Brain, Behavior, and Immunity. PMID 32726685 DOI: 10.1016/j.bbi.2020.07.035   
2020 Spark DL, Mao M, Ma S, Sarwar M, Nowell CJ, Shackleford DM, Sexton PM, Nithianantharajah J, Stewart G, Langmead CJ. In the loop: extra-striatal regulation of spiny projection neurons by GPR52. Acs Chemical Neuroscience. PMID 32519838 DOI: 10.1021/acschemneuro.0c00197   
2020 Costa T, Fernandez-Villalba E, Izura V, Lucas-Ochoa AM, Menezes-Filho NJ, Santana RC, de Oliveira MD, Araújo FM, Estrada C, Silva V, Costa SL, Herrero MT. Combined 1-Deoxynojirimycin and Ibuprofen Treatment Decreases Microglial Activation, Phagocytosis and Dopaminergic Degeneration in MPTP-Treated Mice. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. PMID 32564332 DOI: 10.1007/s11481-020-09925-8   
2020 Lin Y, Tang L, Huang P, Liu T, Zhong J, Xu Q, Li X, Lin Y, Xiao S, Cai J. Mechanisms of Cong Rong Shu Jing Compound Effects on Endoplasmic Reticulum Stress in a Rat Model of Parkinson's Disease. Evidence-Based Complementary and Alternative Medicine : Ecam. 2020: 1818307. PMID 32508943 DOI: 10.1155/2020/1818307   
2020 Bartlett MJ, Flores AJ, Ye T, Smidt SI, Dollish HK, Stancati JA, Farrell DC, Parent KL, Doyle KP, Besselsen DG, Heien ML, Cowen SL, Steece-Collier K, Sherman SJ, Falk T. Preclinical evidence in support of repurposing sub-anesthetic ketamine as a treatment for L-DOPA-induced dyskinesia. Experimental Neurology. 113413. PMID 32717354 DOI: 10.1016/j.expneurol.2020.113413   
2020 Duan WJ, Liang L, Pan MH, Lu DH, Wang TM, Li SB, Zhong HB, Yang XJ, Cheng Y, Liu B, Li WX, Kurihara H, Bi W, Li YF, He RR. Theacrine, a purine alkaloid from kucha, protects against Parkinson's disease through SIRT3 activation. Phytomedicine : International Journal of Phytotherapy and Phytopharmacology. 77: 153281. PMID 32707370 DOI: 10.1016/j.phymed.2020.153281   
2020 Chang KH, Chen CM. The Role of Oxidative Stress in Parkinson's Disease. Antioxidants (Basel, Switzerland). 9. PMID 32650609 DOI: 10.3390/antiox9070597